normalized using the global ratio median. Only gene expression data that were collected from at least 80% of samples from each group were selected for further analysis. Th e unpaired Mann-Whitney test was used to determine statistically signifi cant diff erences in the mRNA expression levels between the RA and healthy groups. Statistical signifi cance was set at P <0.05.
Th e results of our DNA microarray analysis showed that the expressions of four out of the six RA susceptibility genes were signifi cantly higher in RA patients than in healthy individuals (1.0 x 10 -16 to 2.32 x 10 -5 ) ( Table 1 ). As described above, the upregulation of these four genes (CD244, PADI4, SLC22A2, and PTPN22) has been previously confi rmed in in vitro studies. We found, however, that CTLA4 expression levels were similar between the RA and control groups, whereas STAT4 expression was signifi cantly downregulated in the RA group (1.38 x 10 -8 ). We investigated the expression of other RA susceptibility genes -namely, TRF1/C5 [7] , CD40 [8] , and CCL21 [8] -and found that their expressions were similar in both groups. Th e genetic risk factors for RA were recently reported to diff er between Caucasian and Asian (Korean) populations [9] . Th e samples used in our microarray analysis were derived from the same Asian (Japanese) cohort. Th e expression profi les for these three genes may therefore not be consistent with the profi les determined by GWAS.
In this study, we revealed the correlation between fi ve out of the six high-risk RA susceptibility genes using DNA micro array analysis. Prostate cancer susceptibility genes identifi ed by GWAS were recently reported to be consistent with those identifi ed by microarray analysis [10] . We therefore con cluded that the combination of microarray analysis and GWAS would be a more eff ective approach for gene identifi cation than the analysis of individual datasets. Moreover, the simultaneous use of both methods would allow for more accurate identifi cation of RA candidate genes. 
